DexCom, Inc. DXCM and privately-held RxFood Corporation have entered into an agreement to bring their respective expertise together and introduce an improved digital health solution for those with ...
DexCom shares rose in premarket trading Thursday morning after the company said it received regulatory clearance in the U.S. for its diabetes monitoring system. Shares traded 8.5% higher at $72.55.
DexCom has considerably underperformed the S&P 500 over the past year, but analysts are highly optimistic about the stock’s ...
DexCom, Inc. DXCM recently announced the FDA clearance for its 15-day wear G7 Continuous Glucose Monitoring (CGM) system, the longest-lasting and most accurate CGM approved in the United States. This ...
Medical Device Network on MSN
FDA clears Insulet’s Omnipod 5 algorithm enhancements
Insulet anticipates that the Omnipod 5 algorithm update will launch in the US in H1 2026.
The "United States Continuous Glucose Monitoring (CGM) Market, 2025-2033" report has been added to ResearchAndMarkets.com's offering. The United States Continuous Glucose Monitoring (CGM) market size ...
American Diversified Holdings Corporation (OTCID: ADHC) announced today that GlucoGuard has completed the Level 2 App integration through DEXCOM's Developer Program. The project development is in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback